Here's Why Guardant Health Fell 20% in March
Shares of Guardant Health (NASDAQ: GH) fell 20% last month, according to data provided by S&P Global Market Intelligence. The S&P 500 tumbled 12.5% in March as investors grappled with the uncertainty of the coronavirus pandemic. Few stocks were spared, but growth stocks were among the worst performers because they tend to trade at premium valuations. Therefore, they had plenty of room to fall.
Investors should still consider the unique risks facing Guardant Health in light of current events. Operations are likely to be negatively impacted by the coronavirus pandemic, especially as individuals and doctors decide against non-essential medical procedures.
Image source: Getty Images.
Source Fool.com
